Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0128530 MODIFIED PROCEDURE FOR CONTROLLED OVARIAN STIMULATION AND INTRAUTERINE INSEMINATION
A method of using a transfer factor formulation to improve the success rate of a human COS or COS/IUI procedure. The transfer factor formulation consists of at...
2017/0128529 CO-ACTIVATION OF MTOR AND STAT3 PATHWAYS TO PROMOTE NEURONAL SURVIVAL AND REGENERATION
Disclosed herein is a method of promoting sustained survival, sustained regeneration, in a lesioned mature neuron, sustained compensatory outgrowth in a...
2017/0128528 MODIFIED FRIEDREICH ATAXIA GENES AND VECTORS FOR GENE THERAPY
The present invention relates to a modified FXN gene providing for increased expression of the encoded protein frataxin that can be used for treatment of...
2017/0128527 PROLACTIN RECEPTOR ANTAGONISTS FOR TREATMENT OF GLIOBLASTOMA
The present inventor has found that glioblastoma cells respond in unique ways to prolactin (Prl) receptor antagonists. The reaction of glioblastoma cells to...
2017/0128526 STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS
A purified paracrine factor of a mesenchymal stem cell, such as a Secreted frizzled related protein (Sfrp) is useful to reduce cell death an/or tissue injury...
2017/0128525 Administration of Angiocidin for the Treatment of Cancer
Methods are presented for the therapeutic administration of angiocidin in the treatment of cancers such as glioma, breast cancer, and leukemia. Methods are...
2017/0128524 CELL-PERMEABLE PEPTIDE SYSTEM FOR TREATING DISEASES CAUSED BY GLUTAMATE EXCITOTOXICITY
Peptide system including at least one peptide blocking the presynaptic release of glutamate. The peptide has the sequence SEQ ID NO 5: ...
2017/0128523 COMPOSITIONS AND METHODS FOR PROMOTING WOUND HEALING AND TISSUE REGENERATION
Provided herein are compositions and methods for use in promoting wound healing and tissue regeneration following tissue injury in a subject.
2017/0128522 OPHTHALMIC TREATMENT COMPOSITION AND VEHICLE FOR DELIVERY OF PHARMACEUTICAL SUBSTANCES OR THERAPEUTIC AGENTS
An ophthalmic treatment composition for the treatment of dry eye consists essentially of squalane in an amount by weight of 1% to 100%; and mineral oil in an...
2017/0128521 STABILIZED DESMOPRESSIN
The present disclosure relates generally to pharmaceutical compositions comprising an active ingredient and a stabilizing agent, wherein the active ingredient...
2017/0128519 CASPASE INHIBITORS FOR THE TREATMENT OF COLORECTAL CANCER
Provided herein are methods and compositions for treatment of colorectal cancer by administering a caspase inhibitor in combination with chemotherapeutic...
2017/0128518 METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS RESISTANT TO PROTEASOME INHIBITOR TREATMENTS
This document provides methods and materials involved in identifying mammals having blood cancer (e.g., myelomas or lymphomas, including WM, MCL, and DLBCL)...
2017/0128517 COVALENT INHIBITORS OF DUAL OXIDASE 1 (DUOX 1)
The present invention generally relates to inhibitors of DUOX1. In some aspects, an inhibitor may be applied to a subject having or being at risk for asthma or...
2017/0128516 Use for JNK Inhibitor Molecules for Treatment of Various Diseases
The present invention relates to the use of novel JNK inhibitor molecules and their use in a method of treatment of the human or animal body by therapy.
2017/0128515 ANTIMICROBIAL & ANTIVIRAL COMPOSITION
A method of reducing the number of microorganisms entering the nose and proliferating in the nasal cavity including application of a solution of an...
2017/0128514 PHARMACEUTICAL COMPOSITION FOR TREATING CARDIO-CEREBROVASCULAR DISEASES AND METHOD FOR PREPARING THE SAME
A pharmaceutical composition, including, parts by weight of: 100-170 of a ginkgo flavone, 40-100 of a jujube extract, 100-200 of an extract of a peel of...
2017/0128513 CINNAMOMUM BURMANII EXTRACT, EXTRACTION PROCESS AND ITS USE AS PROTON PUMP DOWN-REGULATOR, ENZYME INHIBITOR,...
Extract and/or fraction from Cinnamomum burmanii (DLBS2411) related to its extraction method and its biological activities show activities as antiulcer by...
2017/0128512 Personal Care Compositions With Improved Hyposensitivity
The present invention provides personal care compositions comprising a carrier and a mixture of essential oil components having specific levels of eucalyptol,...
2017/0128511 FORMULATION, METHOD AND APPARATUS FOR CALMING ANIMALS
A formulation and method for calming hunted animals, which is delivered to a geographic region that has been selected for hunting. The formulations and methods...
2017/0128510 GALENICAL SOLID
Preparation process for dietary supplements, comprising at least two steps, the first step of which is to obtain a basic composition comprising liquid...
2017/0128509 SANDALWOOD OIL AND ITS USES RELATED TO CLOSTRIDIUM INFECTIONS
Provided herein are methods of using therapeutically effective compositions of sandalwood oil to treat, prevent or reduce the recurrence of Clostridium...
2017/0128508 NUTRITIONAL SUPPLEMENTS AFFECTING MOOD STATE
Nutritional supplement compositions for mood enhancement are disclosed. A nutritional supplement composition can include one or more of plant material from...
2017/0128507 METHOD OF ISOLATING SPHINGOLIPIDS FROM CORDYCEPS AND THEIR USE
A method of isolating at least one sphingolipid portion selected from a sphingoid base portion, a ceramide portion, a glycosphingolipid portion or a...
2017/0128506 METHODS OF MITIGATING THE NEGATIVE EFFECTS OF RESISTANCE EXERCISE
Methods for inhibiting exercise-induced production of cortisol, exercise-induced production of myeloperoxidase, exercise-induced production of creatine kinase,...
2017/0128505 RNA VIRUSES FOR IMMUNOVIROTHERAPY
The present invention relates to a recombinant virus of the family Paramyxoviridae, comprising at least one expressible polynucleotide encoding a multispecific...
2017/0128504 BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
The present invention relates to a novel bacteriophage having a specific bactericidal activity against salmonella, a composition for the prevention or...
2017/0128503 NEURO-MODULATING PREPARATIONS FOR TREATMENT OF NEUROLOGICAL AND MOOD DISORDERS
Disclosed are compositions of matter, which are extracts of the microalga Aphanizomenon flos Aquae Aquae Rafts ex Born. Rah. Var. flos aquae (AFA-Klamath), and...
2017/0128502 METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM
The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available,...
2017/0128501 Selection and Use of Lactic Acid Bacteria Preventing Bone Loss in Mammals
The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been...
2017/0128500 NUTRITIONAL COMPOSITIONS FOR PROMOTING GUT BARRIER FUNCTION AND AMELIORATING VISCERAL PAIN
The present disclosure is directed to methods for i) promoting gut regeneration, ii) promoting gut maturation and/or adaptation, iii) supporting gut barrier...
2017/0128499 BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL...
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of treating or preventing autoimmune disorders, inhibiting inflammatory...
2017/0128498 PLURIPOTENT STEM CELL FOR TREATMENT OF CHRONIC KIDNEY DISEASE
An object of the present invention is to provide a novel medical application to regenerative medicine that uses pluripotent stem cells (Muse cells). The...
2017/0128497 CO-ENCAPSULATION OF LIVE CELLS WITH OXYGEN-GENERATING PARTICLES
Microcapsules are described that comprise (a) a liquid aqueous or hydrogel core; (b) a semipermeable membrane surrounding said core; (c) live animal cells...
2017/0128496 METHODS AND COMPOSITIONS TO SUPPORT TRANSPLANTED TISSUE INTEGRATION AND INOSCULATION WITH ADIPOSE STROMAL CELLS
The present invention generally relates to methods, compositions and uses thereof for enhancing vascularization of a tissue or cell transplant for ...
2017/0128495 Method of Correcting Pathological Human Skin Conditions Related to Aging
A method correcting pathological human skin conditions caused by aging provides reduction of clinical signs of skin aging and improves functional skin...
2017/0128494 PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION
An object of the present invention is to provide a novel medical application to regenerative medicine that uses pluripotent stem cells (Muse cells). The...
2017/0128493 COMPOSITIONS AND METHODS TO INHIBIT STEM CELL AND PROGENITOR CELL BINDING TO LYMPHOID TISSUE AND FOR...
The present invention relates to compositions and methods of inhibiting stem cell binding to organs and tissues, including the blocking of stem cell binding to...
2017/0128492 STEM CELL THERAPY IN ENDOMETRIAL PATHOLOGIES
The invention generally relates to the ability of autologous CD133+ bone marrow stem cells (BMDSC) to induce endometrial regeneration and treat endometrial...
2017/0128491 CELL IMPLANT FOR ISLET GRAFTS AND USES THEREOF
The present disclosure relates to a cell implant for islet grafts and uses thereof. More specifically, the present disclosure provides a method for treating or...
2017/0128490 METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES
The present invention relates to methods for producing immuno-stimulatory autologous dendritic cells. The present invention further relates to the use of such...
2017/0128489 ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS
Organo-transition metal complexes possess anti-viral inhibitory activity against influenza A, including the S3 IN mutant. The organo-transition metal complexes...
2017/0128488 CHELATED NANOCERIA FOR THE TREATMENT OF OXIDATIVE STRESS
A process for making cerium-containing nanoparticles with biocompatible stabilizers is described, wherein an aqueous reaction mixture comprising cerous ion,...
2017/0128487 ENHANCER OF ANTI-TUMOR EFFECT OF ANTI-CANCER AGENT
An object of the present invention is to provide an agent that potentiates the antitumor effect of an anticancer agent by allowing efficient accumulation of...
2017/0128486 CONSUMABLE COMPOSITIONS AND USES THEREOF FOR ALLEVIATING UNDESIRABLE PHYSIOLOGICAL EFFECTS SYSTEMS
A functional chemical consumption formulated for human consumption and useful for alleviating undesirable physiological effects. The chemical composition may...
2017/0128485 NITRIC OXIDE TREATMENT OF MAMMARY TISSUE
Systems, compositions, devices, and methods for treating a mammary condition in a mammal using gNO delivered from a nitric oxide releasing solution (NORS) are...
2017/0128484 HyperOsmolar Composition of Hyaluronic Acid
The invention relates to a novel hyperosmolar composition of hyaluronic acid for the use thereof in the treatment of corneal oedema.
2017/0128483 HOST DEPENDENCY FACTORS AS TARGETS FOR ANTIVIRAL THERAPY
The present invention relates to inhibitor(s) or antagonist(s) of PADI4 (peptidyl arginine deiminase, type IV), PPAR.delta. (peroxisome proliferator-activated...
2017/0128482 MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR AND RIBAVIRIN
This invention is a novel modified release pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable...
2017/0128481 OCULAR TREATMENT WITH REDUCED INTRAOCULAR PRESSURE
Methods of treating a subject suffering from an ocular infection and/or ocular inflammation are disclosed. The methods include administering to an eye of a...
2017/0128480 Cardiac Glycosides for the Treatment of Hypercholesterolemia
A method of treating hypercholesterolemia in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a cardiac...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.